?

BioSpecifics Technologies Corp. (BSTC) - Financial and Strategic SWOT Analysis Review

Date: May 12, 2015
Pages: 56
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B7C1B1B670EEN
Leaflet:

Download PDF Leaflet

BioSpecifics Technologies Corp. (BSTC) - Financial and Strategic SWOT Analysis Review
BioSpecifics Technologies Corp. (BSTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

BioSpecifics Technologies Corp. (BioSpecifics) is a biopharmaceutical company It has developed injectable collagenase for the treatment of the clinical indications. The company’s injectable collagenase is marketed as Xiaflex (collagenase clostridium histolyticum or CCH) in the US. Xiaflex is used in the treatment of conditions such as Dupuytren's contracture and Peyronie's disease. Biospecifics had partnered with Auxilium Pharmaceuticals, Inc. (Auxilium) for the development and marketing of Xiaflex, under this partnership the company has conducted clinical trials of injectable collagenase for the treatment of conditions such as frozen shoulder and cellulite. The company operates through its partners in Canada, Australia, Brazil, Japan, Mexico and other European countries. BioSpecifics is headquartered in New York, the US.

BioSpecifics Technologies Corp. Key Recent Developments

Apr 22, 2015: BioSpecifics Announces Appointment of Jennifer Chao and Jyrki Mattila, M.D., Ph.D. to Board of Directors
Mar 13, 2015: BioSpecifics Technologies Reports Fourth Quarter and Full Year 2014 Financial Results
Nov 12, 2013: BioSpecifics Technologies Corp. reports third quarter 2013 financial results
Sep 19, 2013: BioSpecifics Technologies to Present at the Aegis Capital 2013 Healthcare Conference
Sep 04, 2013: BioSpecifics Technologies Corp. to Present at the Stifel Nicolaus 2013 Healthcare Conference

Key benefits of buying this profile include::

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

BioSpecifics Technologies Corp. - Key Facts
BioSpecifics Technologies Corp. - Key Employees
BioSpecifics Technologies Corp. - Key Employee Biographies
BioSpecifics Technologies Corp. - Major Products and Services
BioSpecifics Technologies Corp. - Pharmaceutical Pipeline Products Data
BioSpecifics Technologies Corp., Pipeline Products by Therapy Area
BioSpecifics Technologies Corp., Pipeline Products by Development Phase
BioSpecifics Technologies Corp. - History
BioSpecifics Technologies Corp. - Company Statement
BioSpecifics Technologies Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

BioSpecifics Technologies Corp. - Business Description
BioSpecifics Technologies Corp. - Corporate Strategy
BioSpecifics Technologies Corp. - SWOT Analysis
SWOT Analysis - Overview
BioSpecifics Technologies Corp. - Strengths
Strength - Development and Licensing agreements
Strength - R&D in Injectable Collagenase
Strength - Advanced Technological Base
BioSpecifics Technologies Corp. - Weaknesses
Weakness - Higher Cost Structure
BioSpecifics Technologies Corp. - Opportunities
Opportunity - Huge Market to Tap
Opportunity - Demographic Trends
Opportunity - Orphan Drug Status
BioSpecifics Technologies Corp. - Threats
Threat - Intense Competition
Threat - Regulatory Environment
Threat - Uncertain R&D Outcomes
Threat - Dependence on third party manufacturers
BioSpecifics Technologies Corp. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

BioSpecifics Technologies Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
BioSpecifics Technologies Corp., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
BioSpecifics Technologies Corp., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 22, 2015: BioSpecifics Announces Appointment of Jennifer Chao and Jyrki Mattila, M.D., Ph.D. to Board of Directors
Mar 13, 2015: BioSpecifics Technologies Reports Fourth Quarter and Full Year 2014 Financial Results
Nov 10, 2014: BioSpecifics Technologies Reports Third Quarter 2014 Financial Results
Oct 08, 2014: BioSpecifics Technologies Announces Sudden Passing Of Director Max Link, Ph.D.
Aug 11, 2014: BioSpecifics Technologies Reports Second Quarter 2014 Financial Results
Aug 05, 2014: BioSpecifics Technologies Announces Appointment of Max Link, Ph.D. to Board of Directors
Jun 30, 2014: BioSpecifics Technologies to Be Added to Russell 3000 Index
May 08, 2014: BioSpecifics Technologies Reports First Quarter 2014 Financial Results
Mar 06, 2014: BioSpecifics Technologies Reports Fourth Quarter and Full Year 2013 Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
BioSpecifics Technologies Corp., Key Facts
BioSpecifics Technologies Corp., Key Employees
BioSpecifics Technologies Corp., Key Employee Biographies
BioSpecifics Technologies Corp., Major Products and Services
BioSpecifics Technologies Corp., Number of Pipeline Products by Therapy Area
BioSpecifics Technologies Corp., Number of Pipeline Products by Development Stage
BioSpecifics Technologies Corp., Pipeline Products By Therapy Area and Development Phase
BioSpecifics Technologies Corp., History
BioSpecifics Technologies Corp., Subsidiaries
BioSpecifics Technologies Corp., Key Competitors
BioSpecifics Technologies Corp., Ratios based on current share price
BioSpecifics Technologies Corp., Annual Ratios
BioSpecifics Technologies Corp., Interim Ratios
BioSpecifics Technologies Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
BioSpecifics Technologies Corp., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
BioSpecifics Technologies Corp., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES
BioSpecifics Technologies Corp., Pipeline Products by Therapy Area
BioSpecifics Technologies Corp., Pipeline Products by Development Phase
BioSpecifics Technologies Corp., Performance Chart (2010 - 2014)
BioSpecifics Technologies Corp., Ratio Charts
BioSpecifics Technologies Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
BioSpecifics Technologies Corp., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

BioSpecifics Technologies Corp. (BSTC) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: